5-HT1A receptor agonist properties of the antipsychotic, nemonapride: comparison with bromerguride and clozapine (Q48594004)

13 February 2018

http://europepmc.org/abstract/MED/9369342

title

5-HT1A receptor agonist properties of the antipsychotic, nemonapride: comparison with bromerguride and clozapine (English)

1 reference

13 February 2018

http://europepmc.org/abstract/MED/9369342

author name string

Assié MB

series ordinal

1

1 reference

13 February 2018

http://europepmc.org/abstract/MED/9369342

Cosi C

series ordinal

2

1 reference

13 February 2018

http://europepmc.org/abstract/MED/9369342

Koek W

series ordinal

3

1 reference

13 February 2018

http://europepmc.org/abstract/MED/9369342

language of work or name

English

0 references

publication date

1 September 1997

1 reference

13 February 2018

http://europepmc.org/abstract/MED/9369342

published in

European Journal of Pharmacology

1 reference

13 February 2018

http://europepmc.org/abstract/MED/9369342

volume

334

1 reference

13 February 2018

http://europepmc.org/abstract/MED/9369342

issue

2-3

1 reference

13 February 2018

http://europepmc.org/abstract/MED/9369342

page(s)

141-147

1 reference

13 February 2018

http://europepmc.org/abstract/MED/9369342

cites work

Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

(-)-pindolol and (+/-)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Biphasic displacement of [3H]YM-09151-2 binding in the rat brain by thioridazine, risperidone and clozapine, but not by other antipsychotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

5-HT1A receptors are not involved in clozapine's lack of cataleptogenic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Flesinoxan dose-dependently reduces extracellular 5-hydroxytryptamine (5-HT) in rat median raphe and dorsal hippocampus through activation of 5-HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Clozapine decreases serotonin extracellular levels in the nucleus accumbens by a dopamine receptor-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

2-Bromolisuride, an ergot derivative, with dopamine antagonistic and serotonin agonistic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

In vivo characterization of the putative 5-HT1A receptor antagonist SDZ 216,525 using two models of somatodendritic 5-HT1A receptor function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Studies on the role of 5-HT1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release--I. BMY7378 and prazosin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Serotonin-dopamine interaction and its relevance to schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Role of 5-HT1A receptors in the ability of mixed 5-HT1A receptor agonist/dopamine D2 receptor antagonists to inhibit methylphenidate-induced behaviors in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Clozapine inhibits serotoninergic transmission by an action at alpha 1-adrenoceptors not at 5-HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Characterization of a novel and potent 5-hydroxytryptamine1A receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Clozapine has sub-micromolar affinity for 5-HT1A receptors in human brain tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

[76Br]bromolisuride: a new tool for quantitative in vivo imaging of D-2 dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Effects of dopamine antagonists in a two-way active avoidance procedure in rats: interactions with 8-OH-DPAT, ritanserin, and prazosin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Alpha 1-adrenoceptor antagonists differentially control serotonin release in the hippocampus and striatum: a microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Central antidopaminergic properties of 2-bromolisuride, an analogue of the ergot dopamine agonist lisuride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901207-7

10.1016/S0014-2999(97)01207-7

7 January 2021

Identifiers

DOI

1 reference

13 February 2018

http://europepmc.org/abstract/MED/9369342

1 reference

13 February 2018